Trial · NCT00980005
Results by group280
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 280
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Flulaval Group | A/Brisbane [at Day 0] | 46.0 | 95% Confidence Interval 41.9 to 50.4 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Fluzone Group | A/Brisbane [at Day 0] | 45.8 | 95% Confidence Interval 41.8 to 50.2 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Flulaval Group | A/Brisbane [at Day 28] | 320.9 | 95% Confidence Interval 298.3 to 345.2 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Fluzone Group | A/Brisbane [at Day 28] | 329.4 | 95% Confidence Interval 306.8 to 353.7 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Flulaval Group | A/Uruguay [at Day 0] | 57.1 | 95% Confidence Interval 51.8 to 63.0 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Fluzone Group | A/Uruguay [at Day 0] | 63.9 | 95% Confidence Interval 58.1 to 70.3 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Flulaval Group | A/Uruguay [at Day 28] | 414.7 | 95% Confidence Interval 386.5 to 444.9 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Fluzone Group | A/Uruguay [at Day 28] | 451.9 | 95% Confidence Interval 423.8 to 481.8 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Flulaval Group | B/Brisbane [at Day 0] | 16.6 | 95% Confidence Interval 15.3 to 18.1 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Fluzone Group | B/Brisbane [at Day 0] | 16.8 | 95% Confidence Interval 15.4 to 18.3 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Flulaval Group | B/Brisbane [at Day 28] | 213.7 | 95% Confidence Interval 198.5 to 230.1 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains. | Fluzone Group | B/Brisbane [at Day 28] | 200.2 | 95% Confidence Interval 186.1 to 215.3 | Titers |
| Number of Seroconverted Subjects for HI Antibodies Against the Three Strains. | Flulaval Group | A/Brisbane | 590 | Participants | |
| Number of Seroconverted Subjects for HI Antibodies Against the Three Strains. | Fluzone Group | A/Brisbane | 569 | Participants | |
| Number of Seroconverted Subjects for HI Antibodies Against the Three Strains. | Flulaval Group | A/Uruguay | 673 | Participants | |
| Number of Seroconverted Subjects for HI Antibodies Against the Three Strains. | Fluzone Group | A/Uruguay | 647 | Participants | |
| Number of Seroconverted Subjects for HI Antibodies Against the Three Strains. | Flulaval Group | B/Brisbane | 800 | Participants | |
| Number of Seroconverted Subjects for HI Antibodies Against the Three Strains. | Fluzone Group | B/Brisbane | 769 | Participants | |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains, by Age-strata. | Flulaval Group | A/Brisbane at Day 0 [3-4 years] | 38.4 | 95% Confidence Interval 31.5 to 46.7 | Titers |
| Geometric Mean of Haemagglutination Inhibiting (HI) Antibodies Titers Against the Three Strains, by Age-strata. | Fluzone Group | A/Brisbane at Day 0 [3-4 years] | 34.4 | 95% Confidence Interval 28.4 to 41.7 | Titers |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00980005/results